eClinical Solutions Market Expected to Reach USD 7.61 Billion by 2022, with a Remarkable CAGR of 12.4%
Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and increasing R&D expenditure by pharma-biotech companies with augmented IT budgets for drug development are some of the major driving factors for the global eClinical solutions market.
View full press release